PAPERPAC

  • Research type

    Research Study

  • Full title

    PAPERPAC:PAtient PERceptions of long term surveillance in PAncreatic Cancer

  • IRAS ID

    152934

  • Contact name

    Stephen Pereira

  • Contact email

    stephen.pereira@ucl.ac.uk

  • Sponsor organisation

    University College London

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    Background to the study: Pancreatic cancer is associated with a very poor prognosis, 5 year survival in the UK is <4%. However, if diagnosed early prognosis improves significantly (up to 60% 5 year survival for tumours <2cm). A proportion of individuals have an increased risk of developing pancreatic cancer due to a strong family history or because of a pre-malignant lesion within the pancreas e.g. a mucinous pancreatic cyst. These patients are offered surveillance with cross-sectional imaging or endoscopic ultrasound in accordance with international guidance. How patients find their surveillance experience, if they find it reassuring or anxiety provoking and how they assess their cancer risk is largely unknown.

    Study aim: The aims of this study are to evaluate how patients undergoing pancreatic surveillance assess their level of cancer risk and explore how this differs between patients, how it changes over time and if it is influenced by different personal characteristics or management strategies.

    Relevance and importance to patients and the public: The information from this study will inform the improvement of future pancreatic surveillance services.

    Who is eligible: Patients at an increased risk of developing pancreatic cancer who have been offered pancreatic surveillance.

    Sites: The study will be conducted at 6 sites in the UK and 2 in Europe who have a large cohort of patients under regular pancreatic surveillance.

    Study Duration: The study aims to recruit 300 patient over 2 years, beginning in Summer 2015 (patients will remain in the study for 12 months so the study will run for 3 years in total).

  • REC name

    North West - Greater Manchester West Research Ethics Committee

  • REC reference

    15/NW/0729

  • Date of REC Opinion

    8 Sep 2015

  • REC opinion

    Favourable Opinion